{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:18:59Z","timestamp":1789154339623,"version":"build-2803163510"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,4]]},"DOI":"10.7759\/cureus.80013","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:01:07Z","timestamp":1741082467000},"source":"Crossref","is-referenced-by-count":1,"title":["Unraveling the Cause of Perioperative Anaphylaxis: The Role of Patent Blue Dye and Midazolam"],"prefix":"10.7759","author":[{"given":"Beatriz","family":"Lagarteira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Flor de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Bento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e1tia","family":"Santa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.14434","article-title":"Anaphylaxis mortality in the perioperative setting: epidemiology, elicitors, risk factors and knowledge gaps","volume":"54","author":"Pouessel G","year":"2024","unstructured":"Pouessel G, Tacquard C, Tanno LK, Mertes PM, Lezmi G. Anaphylaxis mortality in the perioperative setting: epidemiology, elicitors, risk factors and knowledge gaps. Clin Exp Allergy. 2024, 54:11-20. 10.1111\/cea.14434","journal-title":"Clin Exp Allergy"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner PJ","year":"2017","unstructured":"Turner PJ, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boyle RJ. Fatal anaphylaxis: mortality rate and risk factors. J Allergy Clin Immunol Pract. 2017, 5:1169-78. 10.1016\/j.jaip.2017.06.031","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2018.04.014","article-title":"Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6)","volume":"121","author":"Harper NJ","year":"2018","unstructured":"Harper NJ, Cook TM, Garcez T, et al.. Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6). Br J Anaesth. 2018, 121:159-71. 10.1016\/j.bja.2018.04.014","journal-title":"Br J Anaesth"},{"key":"ref4","article-title":"Drug Allergy: Diagnosis and Management of Drug Allergy in Adults, Children and Young People","author":"National Clinical Guideline Centre (UK)","year":"2014","unstructured":"National Clinical Guideline Centre (UK). Drug Allergy: Diagnosis and Management of Drug Allergy in Adults, Children and Young People. National Institute for Health and Care Excellence (NICE), London; 2014."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/all.12350","article-title":"International Consensus on drug allergy","volume":"69","author":"Demoly P","year":"2014","unstructured":"Demoly P, Adkinson NF, Brockow K, et al.. International Consensus on drug allergy. Allergy. 2014, 69:420-37. 10.1111\/all.12350","journal-title":"Allergy"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13185548","article-title":"Cardiac arrest due to perioperative anaphylactic shock induced by re-exposure to propofol: a case report","volume":"13","author":"Joo J","year":"2024","unstructured":"Joo J, Koh HJ. Cardiac arrest due to perioperative anaphylactic shock induced by re-exposure to propofol: a case report. J Clin Med. 2024, 13:5548. 10.3390\/jcm13185548","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/WOX.0b013e318211496c","article-title":"World allergy organization guidelines for the assessment and management of anaphylaxis","volume":"4","author":"Simons FE","year":"2011","unstructured":"Simons FE, Ardusso LR, Bil\u00f2 MB, et al.. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2011, 4:13-37. 10.1097\/WOX.0b013e318211496c","journal-title":"World Allergy Organ J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2023.02.023","article-title":"The Japanese Epidemiologic Study for Perioperative Anaphylaxis, a prospective nationwide study: clinical signs, severity, and therapeutic agents","volume":"131","author":"Sugiyama Y","year":"2023","unstructured":"Sugiyama Y, Takazawa T, Watanabe N, et al.. The Japanese Epidemiologic Study for Perioperative Anaphylaxis, a prospective nationwide study: clinical signs, severity, and therapeutic agents. Br J Anaesth. 2023, 131:170-7. 10.1016\/j.bja.2023.02.023","journal-title":"Br J Anaesth"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(77)91953-5","article-title":"Incidence and severity of anaphylactoid reactions to colloid volume substitutes","volume":"26","author":"Ring J","year":"1977","unstructured":"Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977, 26:466-9. 10.1016\/s0140-6736(77)91953-5","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01347.x","article-title":"Anaphylaxis during anaesthesia: diagnostic approach","volume":"62","author":"Ebo DG","year":"2007","unstructured":"Ebo DG, Fisher MM, Hagendorens MM, Bridts CH, Stevens WJ. Anaphylaxis during anaesthesia: diagnostic approach. Allergy. 2007, 62:471-87. 10.1111\/j.1398-9995.2007.01347.x","journal-title":"Allergy"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2023.09.015","article-title":"Anaphylaxis: a 2023 practice parameter update","volume":"132","author":"Golden DB","year":"2024","unstructured":"Golden DB, Wang J, Waserman S, et al.. Anaphylaxis: a 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024, 132:124-76. 10.1016\/j.anai.2023.09.015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2009.03404.x","article-title":"BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia","volume":"40","author":"Ewan PW","year":"2010","unstructured":"Ewan PW, Dugu\u00e9 P, Mirakian R, Dixon TA, Harper JN, Nasser SM. BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin Exp Allergy. 2010, 40:15-31. 10.1111\/j.1365-2222.2009.03404.x","journal-title":"Clin Exp Allergy"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.08.006","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs","volume":"8","author":"Broyles AD","year":"2020","unstructured":"Broyles AD, Banerji A, Barmettler S, et al.. Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs. J Allergy Clin Immunol Pract. 2020, 8:S16-S116. 10.1016\/j.jaip.2020.08.006","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2009.02248.x","article-title":"Anaphylaxis to patent blue V: a case series and proposed diagnostic protocol","volume":"65","author":"Haque RA","year":"2010","unstructured":"Haque RA, Wagner A, Whisken JA, Nasser SM, Ewan PW. Anaphylaxis to patent blue V: a case series and proposed diagnostic protocol. Allergy. 2010, 65:396-400. 10.1111\/j.1398-9995.2009.02248.x","journal-title":"Allergy"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","article-title":"General considerations for skin test procedures in the diagnosis of drug hypersensitivity","volume":"57","author":"Brockow K","year":"2002","unstructured":"Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy. 2002, 57:45-51.","journal-title":"Allergy"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.15586\/aei.v49i4.238","article-title":"Allergic reactions to midazolam: a case series from an Italian allergy unit","volume":"49","author":"Nucera E","year":"2021","unstructured":"Nucera E, Parrinello G, Buonomo A, Aruanno A, Rizzi A. Allergic reactions to midazolam: a case series from an Italian allergy unit. Allergol Immunopathol (Madr). 2021, 49:167-70. 10.15586\/aei.v49i4.238","journal-title":"Allergol Immunopathol (Madr)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/203058-unraveling-the-cause-of-perioperative-anaphylaxis-the-role-of-patent-blue-dye-and-midazolam","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:01:09Z","timestamp":1741082469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/203058-unraveling-the-cause-of-perioperative-anaphylaxis-the-role-of-patent-blue-dye-and-midazolam"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.80013","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,4]]}}}